Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
- PMID: 25353003
- PMCID: PMC4209361
- DOI: 10.1016/j.molmet.2014.07.010
Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
Abstract
Objective: Exploitation of protective metabolic pathways within injured myocardium still remains an unclarified therapeutic target in heart disease. Moreover, while the roles of altered fatty acid and glucose metabolism in the failing heart have been explored, the influence of highly dynamic and nutritionally modifiable ketone body metabolism in the regulation of myocardial substrate utilization, mitochondrial bioenergetics, reactive oxygen species (ROS) generation, and hemodynamic response to injury remains undefined.
Methods: Here we use mice that lack the enzyme required for terminal oxidation of ketone bodies, succinyl-CoA:3-oxoacid CoA transferase (SCOT) to determine the role of ketone body oxidation in the myocardial injury response. Tracer delivery in ex vivo perfused hearts coupled to NMR spectroscopy, in vivo high-resolution echocardiographic quantification of cardiac hemodynamics in nutritionally and surgically modified mice, and cellular and molecular measurements of energetic and oxidative stress responses are performed.
Results: While germline SCOT-knockout (KO) mice die in the early postnatal period, adult mice with cardiomyocyte-specific loss of SCOT (SCOT-Heart-KO) remarkably exhibit no overt metabolic abnormalities, and no differences in left ventricular mass or impairments of systolic function during periods of ketosis, including fasting and adherence to a ketogenic diet. Myocardial fatty acid oxidation is increased when ketones are delivered but cannot be oxidized. To determine the role of ketone body oxidation in the remodeling ventricle, we induced pressure overload injury by performing transverse aortic constriction (TAC) surgery in SCOT-Heart-KO and αMHC-Cre control mice. While TAC increased left ventricular mass equally in both groups, at four weeks post-TAC, myocardial ROS abundance was increased in myocardium of SCOT-Heart-KO mice, and mitochondria and myofilaments were ultrastructurally disordered. Eight weeks post-TAC, left ventricular volume was markedly increased and ejection fraction was decreased in SCOT-Heart-KO mice, while these parameters remained normal in hearts of control animals.
Conclusions: These studies demonstrate the ability of myocardial ketone metabolism to coordinate the myocardial response to pressure overload, and suggest that the oxidation of ketone bodies may be an important contributor to free radical homeostasis and hemodynamic preservation in the injured heart.
Keywords: Mitochondrial metabolism; Myocardial ketone body metabolism; Nuclear magnetic resonance (NMR) measurement of substrate metabolism; Oxidative stress; Ventricular remodeling.
Figures
Similar articles
-
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.Circulation. 2020 Jun 2;141(22):1800-1812. doi: 10.1161/CIRCULATIONAHA.119.045033. Epub 2020 Jun 1. Circulation. 2020. PMID: 32479196 Free PMC article. Review.
-
Cardiac-Specific Bdh1 Overexpression Ameliorates Oxidative Stress and Cardiac Remodeling in Pressure Overload-Induced Heart Failure.Circ Heart Fail. 2017 Dec;10(12):e004417. doi: 10.1161/CIRCHEARTFAILURE.117.004417. Circ Heart Fail. 2017. PMID: 29242353
-
Ketone body metabolism and its defects.J Inherit Metab Dis. 2014 Jul;37(4):541-51. doi: 10.1007/s10545-014-9704-9. Epub 2014 Apr 8. J Inherit Metab Dis. 2014. PMID: 24706027 Review.
-
Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation.Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E363-74. doi: 10.1152/ajpendo.00547.2012. Epub 2012 Dec 11. Am J Physiol Endocrinol Metab. 2013. PMID: 23233542 Free PMC article.
-
Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment.J Biol Chem. 2010 Aug 6;285(32):24447-56. doi: 10.1074/jbc.M110.100651. Epub 2010 Jun 7. J Biol Chem. 2010. PMID: 20529848 Free PMC article.
Cited by
-
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.J Pharm Pharm Sci. 2024 Apr 19;27:12568. doi: 10.3389/jpps.2024.12568. eCollection 2024. J Pharm Pharm Sci. 2024. PMID: 38706718 Free PMC article. Review.
-
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.Cardiovasc Diabetol. 2024 Apr 27;23(1):145. doi: 10.1186/s12933-024-02221-2. Cardiovasc Diabetol. 2024. PMID: 38678253 Free PMC article. Clinical Trial.
-
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets.Cell Death Discov. 2024 Feb 14;10(1):78. doi: 10.1038/s41420-023-01792-5. Cell Death Discov. 2024. PMID: 38355681 Free PMC article. Review.
-
Circulating 3-hydroxy butyrate predicts mortality in patients with chronic heart failure with reduced ejection fraction.ESC Heart Fail. 2024 Apr;11(2):837-845. doi: 10.1002/ehf2.14476. Epub 2024 Jan 9. ESC Heart Fail. 2024. PMID: 38196294 Free PMC article.
-
Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress.Redox Biol. 2024 Feb;69:103010. doi: 10.1016/j.redox.2023.103010. Epub 2023 Dec 27. Redox Biol. 2024. PMID: 38160540 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials